Acute Revascularization in ST-Segment-Elevation Myocardial Infarction

Cardiovascular Disease and Stroke (P Perrone-Filardi and S. Agewall, Section Editors)

DOI: 10.1007/s11883-014-0412-6

Cite this article as:
Prodanov, P. & Widimsky, P. Curr Atheroscler Rep (2014) 16: 412. doi:10.1007/s11883-014-0412-6
Part of the following topical collections:
  1. Topical Collection on Cardiovascular Disease and Stroke


We briefly and comprehensively present some of the novel findings in the field of revascularization therapy and management of ST-segment-elevation myocardial infarction (STEMI). We highlight the latest evidence-based advancements in the pharmacological and mechanical treatment of patients who presented with STEMI. Since the last updates to the international guidelines (American College of Cardiology/American Heart Association and the European Society of Cardiology) were published in 2011 and 2012, there have been changes and several important studies have presented their final outcomes. We also highlight some controversial approaches as part of the current debates in the cardiology community. In addition, we share our recent experience in the field of biodegradable scaffold stents as a treatment strategy in STEMI.


Acute revascularization Myocardial infarction Percutaneous coronary intervention Fibrinolysis Antiplatelet therapy Balloon angioplasty Stenting Direct stenting Bioresorbable vascular scaffold Biodegradable stent Multivessel disease Bypass grafting 

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Cardiocenter, Third Faculty of MedicineCharles University and University Hospital Kralovske VinohradyPrague 10Czech Republic

Personalised recommendations